Rocket Lab (RKLB) Falls -21% in a Month Despite Record Revenue

Key Takeaways

• RKLB fell roughly 21% over the last 30 days, from about $80 to the low-$60s, extending a multi-month pullback from its 52-week high.
• The decline came even as the company reported record second-quarter revenue of $234.1 million, up 62% year over year, and a record $2.36 billion backlog.
• Softer margin guidance, wider expected EBITDA losses, and a narrowing window for the Neutron rocket's first launch weighed on investor sentiment.
• Insider selling and an elevated valuation added to pressure, even as ARK Invest added roughly $45 million to its position.
• Wall Street remains broadly constructive, with a consensus Strong Buy rating and an average price target well above recent trading levels.

Understanding Rocket Lab USA's (RKLB) Business and Position

Rocket Lab USA, Inc. designs, builds, and launches rockets and satellites for commercial and government customers. Its launch operations center on the Electron small-lift rocket and the HASTE suborbital variant for hypersonic and defense work. The company is also advancing Neutron, a reusable medium-lift vehicle aimed at competing more directly with established players like SpaceX.

In addition to launches, Rocket Lab runs a growing Space Systems segment that produces satellites, components, solar cells, and software. This vertical integration, paired with a substantial backlog across both segments, gives the company a distinctive profile in the space sector. I find the mix of launch cadence and hardware manufacturing particularly worth monitoring as national-security spending and commercial demand continue to expand.

RKLB Stock Performance Over the Past 30 Days and Quarter

Over the last 30 days, RKLB declined roughly 21%, moving from a closing price near $80 to approximately $63. The drop extended a broader slide that saw the stock fall about 38% over the past quarter, from the low-$100s in mid-June to the low-$60s. From its 52-week high near $151 in late May 2026, the shares are down more than 50%, although they remain higher over the trailing twelve months.

The movement looks more like a valuation reset than any fundamental breakdown. Revenue, backlog, and launch demand have all hit new highs, yet the market has applied a lower multiple to this high-growth name while key milestones, especially the first Neutron flight, are still ahead. I also checked this using Tickeron’s AI Screener to compare valuation multiples across the broader aerospace group.

Factors Behind the Recent 30-Day Decline

The main driver was the second-quarter 2026 earnings release in early August. Results showed record revenue of $234.1 million, up 62% year over year, and backlog reaching $2.36 billion, up 137% from a year earlier. Still, the stock traded lower after hours as investors focused on profitability details and timing.

The company posted a loss of $0.08 per share, wider than the roughly $0.06 analysts had projected. Third-quarter guidance called for revenue of $250 million to $265 million, which topped expectations, but also pointed to softer gross margins and an adjusted EBITDA loss of $17 million to $23 million. Management cited a shift toward lower-margin satellite platforms, integration expenses, and ongoing Neutron investment. Free cash flow was a use of $110.1 million in the quarter.

Neutron timing added to the pressure. The company still targets delivering the first vehicle to the pad in the fourth quarter of 2026, but the window for a year-end launch is narrowing, raising the possibility of a slip into 2027. Because Neutron is central to the long-term story, any delay tends to weigh on the shares. Several executives sold shares in August and early September under pre-arranged plans, and the stock’s elevated price-to-sales ratio left it exposed during sector volatility. On the positive side, ARK Invest added roughly 705,000 shares worth about $45 million, and Rocket Lab introduced a new germanium-free solar cell with improved efficiency.

Drivers of the Quarterly Pullback

The larger quarterly decline followed a sharp rally that peaked near $151 in late May 2026. An earlier first-stage tank pressure-test failure on Neutron had already shifted the expected debut from mid-2026 toward year-end, introducing fresh execution risk. At the same time, Rocket Lab completed acquisitions of Mynaric and Motiv and announced an agreement to acquire Iridium Communications (IRDM), expected to close in mid-2027. These moves bolster vertical integration and recurring revenue but also bring near-term costs. Combined with high valuation and broader scrutiny of space stocks, the market moved from momentum pricing to execution focus, even as operating results remained strong.

Key Items to Watch for RKLB Going Forward

Neutron remains the central near-term variable. Investors will track whether the vehicle reaches the pad in the fourth quarter of 2026 and whether the first flight occurs before year-end or moves into 2027. Management has indicated that a successful first Neutron test flight should mark an inflection for profitability, with adjusted EBITDA turning positive in the following quarter and standalone cash-flow positivity targeted 18 to 24 months later.

Additional items to follow include the Iridium acquisition closing and related regulatory steps, the path of gross margins and cash burn, and the conversion of the record backlog, with roughly 45% expected to turn into revenue within twelve months. Third-quarter results will show whether revenue growth can be sustained alongside margin management. Macro conditions, interest-rate moves, and sentiment toward high-multiple growth stocks will also influence the multiple.

Using Tickeron’s AI Tools in My Research

When evaluating names like this, I often turn to Tickeron’s AI Daily Buy/Sell Signals to cross-check short-term momentum against the longer-term fundamental picture. The platform lets me quickly scan how RKLB stacks up against peers on a range of quantitative metrics, which helps keep the analysis grounded in data rather than headlines alone.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Contributor

Arthur Evans|Expert

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.

Notable companies

Industry description

Market Cap

High and low price notable news

Volume